Literature DB >> 22488075

Update on coxsackievirus B3 myocarditis.

DeLisa Fairweather1, Katelyn A Stafford, Yoon K Sung.   

Abstract

PURPOSE OF REVIEW: To present recent findings on the pathogenesis of coxsackievirus B3 (CVB3) myocarditis based on animal models, with a focus on the role of T helper (Th) immune responses in disease progression. RECENT
FINDINGS: Acute CVB3 myocarditis is known to be increased by Th1 immune responses, but recent findings indicate that Th1-type immunity protects against acute myocarditis by reducing viral replication and prevents the progression to chronic myocarditis and dilated cardiomyopathy (DCM) by inhibiting Th2 responses. Th2 responses reduce acute myocarditis by inhibiting Th1 responses via regulatory T cells and anti-inflammatory cytokines, but can be deleterious when they induce acute cardiac remodeling leading to chronic myocarditis/DCM. Th2-skewed immune responses allow resistant strains of mice to progress from myocarditis to DCM. In contrast, Th17 responses are elevated during acute and chronic myocarditis and have been found to contribute to cardiac remodeling and DCM.
SUMMARY: Recent data indicate that elevated Th2 and Th17 responses during acute CVB3 myocarditis are critical for the progression from myocarditis to DCM and heart failure because of their ability to induce cardiac remodeling. Th1 responses protect against CVB3 myocarditis by inhibiting Th2 responses and viral replication, but increase acute inflammation.

Entities:  

Mesh:

Year:  2012        PMID: 22488075      PMCID: PMC4536812          DOI: 10.1097/BOR.0b013e328353372d

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  61 in total

1.  Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.

Authors:  Yuquan Xie; Ruizhen Chen; Xian Zhang; Yong Yu; Yingzhen Yang; Yunzeng Zou; Junbo Ge; Haozhu Chen; Alfredo Garzino-Demo
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-22

2.  Why is diagnosis of infectious myocarditis such a challenge?

Authors:  Heinz-Peter Schultheiss; Uwe Kühl
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

Review 3.  Fulminant myocarditis.

Authors:  Sachin Gupta; David W Markham; Mark H Drazner; Pradeep Pa Mammen
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-09-16

Review 4.  Cardiomyopathy: an overview.

Authors:  Randell K Wexler; Terry Elton; Adam Pleister; David Feldman
Journal:  Am Fam Physician       Date:  2009-05-01       Impact factor: 3.292

5.  Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.

Authors:  G Christian Baldeviano; Jobert G Barin; Monica V Talor; Sachin Srinivasan; Djahida Bedja; Dongfeng Zheng; Kathleen Gabrielson; Yoichiro Iwakura; Noel R Rose; Daniela Cihakova
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 6.  Autoimmunity in coxsackievirus B3 induced myocarditis.

Authors:  Sally A Huber
Journal:  Autoimmunity       Date:  2006-02       Impact factor: 2.815

7.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Sex-related differences in the pattern of coxsackievirus B-3-induced immune spleen cell cytotoxicity against virus-infected myofibers.

Authors:  S A Huber; L P Job; J F Woodruff
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice.

Authors:  Jennifer A Onyimba; Michael J Coronado; Amanda E Garton; Joseph B Kim; Adriana Bucek; Djahida Bedja; Kathleen L Gabrielson; Tomas R Guilarte; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2011-02-21       Impact factor: 5.027

10.  Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.

Authors:  Kapka Miteva; Marion Haag; Jun Peng; Kostas Savvatis; Peter Moritz Becher; Martina Seifert; Katrin Warstat; Dirk Westermann; Jochen Ringe; Michael Sittinger; Heinz-Peter Schultheiss; Carsten Tschöpe; Sophie Van Linthout
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

View more
  50 in total

1.  Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.

Authors:  Maowei Wang; Yan Yue; Chunsheng Dong; Xiaoyun Li; Wei Xu; Sidong Xiong
Journal:  Clin Vaccine Immunol       Date:  2013-09-11

2.  Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.

Authors:  Eiichiro Kawai; Fumitaka Sato; Seiichi Omura; Nicholas E Martinez; Pratap C Reddy; Masaru Taniguchi; Ikuo Tsunoda
Journal:  J Neuroimmunol       Date:  2014-11-08       Impact factor: 3.478

3.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

Review 4.  Complexities in the relationship between infection and autoimmunity.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 5.  Advances in Cardiovascular MRI using Quantitative Tissue Characterisation Techniques: Focus on Myocarditis.

Authors:  Rocio Hinojar; Eike Nagel; Valentina O Puntmann
Journal:  Eur Cardiol       Date:  2016-08

6.  Isolation and genetic characterization of enterovirus in patients with febrile rash illness.

Authors:  Zhaohui Ni; Fengyang Xiang; Honglan Huang; Guoqing Wang; Fan Li
Journal:  Biomed Rep       Date:  2015-03-05

7.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

Review 8.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

9.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

10.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.